Suscribirse

Characteristics of infections and their risk factors in children with biliary atresia - 31/03/23

Doi : 10.1016/j.clinre.2023.102109 
Henry Shiau a, , Jeremy M. Schraw b, c, Krupa Mysore a, Laurel Cavallo a, Sanjiv Harpavat a, Philip J. Lupo b, c, Flor M. Munoz d, Benjamin L. Shneider a
a Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, U.S.A. 
b Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, Texas, U.S.A. 
c Texas Children's Cancer and Hematology Centers, Texas Children's Hospital, Houston, Texas, U.S.A. 
d Department of Pediatrics, Section of Infectious Diseases, Molecular Virology and Microbiology, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, U.S.A. 

Corresponding author at: Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, The University of Alabama at Birmingham, Children's of Alabama, 5604 McWane Building, Dearth Tower Birmingham, AL 35233-1711.Division of Gastroenterology, Hepatology, and Nutrition, Department of PediatricsThe University of Alabama at Birmingham, Children's of Alabama5604 McWane Building, Dearth Tower BirminghamAL35233-1711

Highlights

The infectious course of children with biliary atresia (BA) post-kasai is described.
Cluster analysis recognizes three distinct infectious cohorts of children with BA.
Age at kasai and platelets 1-month post-kasai are potential infectious risk factors.

El texto completo de este artículo está disponible en PDF.

Abstract

Background

Children with biliary atresia (BA) may experience various infections (e.g., cholangitis, bacteremia, and viral respiratory infections (VRI)) throughout their disease course. This study aimed to identify and describe these infections and their risk factors for development in children with BA.

Methods

This retrospective observational study identified infections in children with BA using predefined criteria, including VRI, bacteremia with and without central line (CL), bacterial peritonitis, positive stool pathogens, urinary tract infections, and cholangitis. Infections were identified until liver transplant, death or last follow-up with native liver. Infection-free survival was estimated by Kaplan-Meier analysis. Logistic regression was used to estimate odds of infection per clinical characteristics. Cluster analysis was performed to identify patterns of infection development.

Results

48 of 65 (73.8%) children had ≥1 infection during their disease course (mean length of follow up: 40.2 months). Cholangitis (n = 30) and VRI (n = 21) were most common. Nearly half (45%) of all infections developed within 3-months of Kasai hepatoportoenterostomy. Kasai performed ≥45 days of life was associated with 3.5-fold increased risk of any infection (95% CI 1.2–11.4). Risk of VRI was inversely related to platelet count at 1-month post-Kasai (OR 0.5, 0.19–0.99). Cluster analysis of infectious patterns identified three unique cohorts of patients based on their infection history: no/few infections (n = 18), mostly cholangitis (n = 20) or mixed infections (n = 27).

Conclusion

Variability of infection risk exists amongst children with BA. Age at Kasai and platelet count are risk factors for future infections, suggesting that patients with more severe disease are at greater risk. Cirrhosis associated immune deficiency may exist in chronic pediatric liver disease and should be the subject of future investigations in order to optimize outcomes.

El texto completo de este artículo está disponible en PDF.

Keywords : Viral respiratory infections, Bacteremia, Central line infections, Cholangitis, Kasai hepatoportoen-terostomy, Cirrhosis

Abbreviations : BA, CAID, CL, CLABSI, CLD, CRF, EMR, HPE, LT, PCR, PICC, RSV, SBP, UTI, VRI


Esquema


© 2023  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 47 - N° 4

Artículo 102109- avril 2023 Regresar al número
Artículo precedente Artículo precedente
  • MAdCAM-1 does not play a central role in the early pathophysiology of autoimmune hepatitis
  • F.F. van den Brand, H. Masrati, E.S. Jordanova, E. Bloemena, B.I. Lissenberg-Witte, Y.S. de Boer, H.J. Bontkes, R. Mebius, G. Bouma
| Artículo siguiente Artículo siguiente
  • An involvement of Hippo-yes-associated protein pathway in biliary epithelial senescence in primary biliary cholangitis
  • Motoko Sasaki, Yasunori Sato, Yasuni Nakanuma

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.